ESG Data

Environment

Greenhouse Gas Emissions (Own Emissions)

Unit FY2021 FY2022 FY2023
Scope 1 t-CO2 30,700 28,439 31,081
Scope 2 t-CO2 46,996 46,552 42,494
Scope 1 + Scope 2 t-CO2 77,696 74,991 73,575
Calculated based on data from MEDIPAL HOLDINGS CORPORATION and consolidated subsidiaries

Greenhouse Gas Emissions (Scope3)*1

Unit FY2021 FY2022*2 FY2023
Category 2: Capital goods t-CO2 - 60,401 72,953
Category 3: Fuel-and energy-related activities (not included in scope 1 or scope 2) t-CO2 - 17,304 14,990
Category 4: Upstream transportation and distribution t-CO2 - 110,073 68,622
Category 5: Waste generated in operations t-CO2 - 826 1,202
Category 6: Business travel t-CO2 - 1,572 1,176
Category 7: Employee commuting t-CO2 - 23,268 41,858
Category 13: Downstream leased assets t-CO2 - 2,728 2,106
Category 15: Investments t-CO2 - 12,601 16,743

Calculated following materials
a) Basic guidelines for accounting for greenhouse gas emissions throughout the supply chain ver.2.6 (Ministry of the environment, Ministry of Economy, Trade and Industry)
b) Emission intensity database for calculating greenhouse gas emissions, etc. of an organization through the supply chain ver.3.4 (Ministry of the environment, Ministry of Economy, Trade and Industry)
c) LCI data base IDEAv2 (Sustainable Management Promotion Organization)

  • *1 Publicly disclosed from FY2022. We are in the process of carefully examining other categories to increase the accuracy of calculations.
  • *2 Implemented at MEDIPAL HOLDINGS CORPORATION, MEDICEO CORPORATION, EVERLTH Co., Ltd., ATOL CO., LTD., MM CORPORATION, PALTAC CORPORATION, MP AGRO CO., LTD., and MEDIPAL FOODS CORPORATION
Calculated based on data from MEDIPAL HOLDINGS CORPORATION and consolidated subsidiaries

Energy usage

Unit FY2021 FY2022 FY2023
Fuel Gasoline kL 11,272 10,415 11,927
Diesel oil kL 1,024 914 858
Kerosene* kL - 39 72
Class A heavy oil* kL - 327 146
LP gas* t - 9 9
City gas* Nm3 - 392,000 404,000
Electricity kWh 109,097,000 110,507,000 113,913,000
Of which renewable energy kWh 0 3,144,000 16,490,000
Proportion % 0 2.8 14.5

* Announced from the FY2022

  • Calculated based on data from MEDIPAL HOLDINGS CORPORATION and consolidated subsidiaries

Social

Unit FY2021*2 FY2022*3 FY2023
Managerial roles filled by women rate*1 % 7.3 7.9 8.5
Employees with disabilities rate*1 % 2.53 2.54 2.66
Male employees taking childcare leave rate % 7.0 20.1 48.1
Paid Leave Usage rate % 50.0 58.2 56.8
Overtime Work (Monthly Average) Hours 10.9 10.5 9.9
Calculated based on data from MEDIPAL HOLDINGS CORPORATION and consolidated subsidiaries
  • *1 As of March 31
  • *2 Calculated based on data from MEDIPAL HOLDINGS CORPORATION, MEDICEO CORPORATION, EVERLTH Co., Ltd., ATOL CO., LTD., MM CORPORATION, PALTAC CORPORATION, MP AGRO CO., LTD., MEDIPAL FOODS CORPORATION
  • *3 Calculated based on data from the companies included in the FY2021 data plus MEDISKET CORPORATION and MP Gokyo Food & Chemical Co., Ltd.

Governance

Overview of the Corporate Governance

Unit FY2021 FY2022 FY2023
Directors Number of Directors - 12 12 12
Number of outside directors - 4 4 4
Outside directors rate % 33.3 33.3 33.3
Number of female directors - 2 2 2
Female directors rate % 16.7 16.7 16.7
Audit & Supervisory Board members Number of Audit & Supervisory Board members - 5 5 5
Number of outside Audit & Supervisory Board members - 3 3 3
Outside Audit & Supervisory Board members rate % 60.0 60.0 60.0
Number of female Audit & Supervisory Board members - 1 1 1
Female Audit & Supervisory Board members rate % 20.0 20.0 20.0
Nomination Committee members Number of Nomination Committee members - 6 6 6
Number of outside directors - 4 4 4
Outside directors rate % 66.7 66.7 66.7
Compensation Committee members Number of Compensation Committee members - 6 6 6
Number of outside directors - 4 4 4
Outside directors rate % 66.7 66.7 66.7
Compliance Committee Number of Compliance Committee - 5 5 5
Number of outside directors - 2 2 2
Outside directors rate % 40.0 40.0 40.0

Meetings in the Fiscal Year Ended

Unit FY2021 FY2022 FY2023
Board of Directors Number of meetings Times 13 15 13
Attendance by outside directors % 96.2 95.0 92.3
Attendance by outside Audit & Supervisory Board members % 97.4 97.8 97.1
Audit & Supervisory Board Number of meetings Times 13 13 13
Attendance by outside Audit & Supervisory Board members % 100 97.4 100
Nomination Committee Number of meetings Times 3 6 3
Attendance by outside directors % 83.3 95.8 91.7
Compensation Committee Number of meetings Times 3 2 3
Attendance by outside directors % 83.3 100 91.7
Compliance Committee Number of meetings Times 4 4 4
Attendance by outside directors % 100 100 75.0

Status of Strategic Shareholdings

Unit FY2021 FY2022 FY2023
Strategic Shareholdings Number of issuers Issues 82 74 70
Total amount on balance sheet Millions of yen 105,904 96,725 100,881

Compensation for Directors

Unit FY2021 FY2022 FY2023
Total Amount of Compensation Directors (Number of Relevant Corporate Officers) Millions of yen（Persons） 267 (8) 264 (9) 255 (9)
Audit & Supervisory Board members (Number of Relevant Corporate Officers) Millions of yen (Persons) 48 (2) 48 (2) 46 (3)
Outside Directors (Number of Relevant Corporate Officers) Millions of yen (Persons) 57 (5) 57 (4) 57 (4)
Outside Audit & Supervisory Board members (Number of Relevant Corporate Officers) Millions of yen (Persons) 32 (3) 32 (3) 32 (4)
  • Calculated based on data from MEDIPAL HOLDINGS CORPORATION